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Yushima 1-5-45, Bunkyo-ku, Tokyo, Japan
b Department of Dentistry and Oral Surgery, Secomedic Hospital, 696-1, Toyotomi-cho,
Funabashi-shi, Chiba, JapanReceived 8 June 2005; accepted 9 June 2005Summary A rare case of solitary fibrous tumor occurring in the tongue is
described. An 80-year old woman presented with a slow-growing painless mass in
the apex of the tongue. Under a clinical diagnosis of benign tongue tumor, surgical
excision was performed. The tumor was a submucosal well-demarcated mass of two
centimeters in diameter. Microscopically, spindle-shaped tumor cells were haphaz-
ardly arranged in sheets, fascicles or whirling patterns with thick collagen bundles
and marked capillary proliferation. Immunohistochemically, tumor cells were posi-
tive for vimentin, CD34 and Bcl-2, but negative for EMA, CD99 and S-100. Some
tumor cells were positive for smooth muscle actin and also for angiogenic factors,
such as VEGF, bFGF and their receptors, suggesting strong inclination to angiogenic
differentiation. Although the tumor showed few signs of malignancy, a high labeling
index of p53 was noted, implying a potential for malignant transformation.c 2005 Elsevier Ltd. All rights reserved.
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0Introduction
Solitary fibrous tumor (SFT) is a neoplasm that
arises most commonly in pleura. Although SFT
occasionally occurs in extrapleural locations, the
incidence in the oral cavity is rare, especially in
the tongue.
We describe a case of SFT in the tongue
along with the result of immunohistochemical
examination.741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reser
oi:10.1016/j.ooe.2005.06.005
* Corresponding author. Tel.: +81 3 5803 5454; fax: +81 3 5803
188.
E-mail address: s-kei.mpa@tmd.ac.jp (K. Sakamoto).Case report
An 80-year old woman presented with a painless
submucosal mass in the apex of the tongue and
was referred to the Secomedic Hospital (Fig. 1A).
The patient had first noticed the nodule two
years earlier. Her previous medical history was
uneventful and no remarkable family history was
noted. No unusual features were noted on extra-
oral examination. Under a clinical diagnosis of
benign tongue tumor, surgical excision was per-
formed using local anesthesia. No recurrence or
metastasis has been observed during a one-year
follow-up period.ved.
Figure 1 (A) Macroscopic view of the tumor before resection. (B) The tumor locates in the subepithelial connective
tissue without distinct fibrous capsule, although the tumor was well-demarcated. (C) Thick collagen bundles ran
parallel between the tumor cells. (D) The tumor cells are spindle-shaped and haphazardly arranged, and a pericytic
pattern was also observed (B, C, D: HE staining; original magnification: B ·20, C ·100, D ·200).
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round, white, elastic-hard, well-demarcated and
measuring 25 · 20 · 20 mm. Microscopically, the
tumor consisted of spindle-shaped cells, haphaz-
ardly arranged in sheets, fascicles or whirling pat-
terns. In some areas, thick collagen bundles ran
parallel between the tumor cells (Fig. 1B and C).
Capillary proliferation was prominent and a peri-
cytic pattern of tumor cell proliferation was seen
(Fig. 1D). Hypercellular areas existed, but cellular
atypia was unremarkable and mitotic figure was
rare (less than 1 per square millimeter). Necrotic
foci were not observed. The tumor was well cir-
cumscribed, but fibrous capsules did not exist and
the tumor cells proliferated continuously into the
surrounding connective tissues (Fig. 1B).
Immunohistochemically, the tumor cells were
strongly positive for vimentin and CD34 (Fig. 2A).
Von Willebrand factor (vWf) was positive only in
the well-formed capillary lumens. However, a-
smooth muscle actin (SMA) was positive in some
tumor cells that did not constitute capillaries, as
well as in capillary cells (Fig. 2B and C). Most of
the tumor cells were positive for vascular endothe-
lial growth factor (VEGF) (Fig. 2D), its type two
receptor (VEGF-R2) (Fig. 2E), basic FGF (bFGF)
and its receptor (FGF-R). The majority (60%) of tu-
mor cells were positive for Bcl-2. Ki-67 labeling in-
dex was less than 10%. p53 labeling index was high
and was approximately 50% (Fig. 2F). The tumor
cells were negative for epithelial membrane anti-gen (EMA), Desmin, CD99, S-100 and MDM2. The
immunohistochemical results are summarized in
Table 1.Discussion
SFT is a spindle cell fibrous and myofibroblastic
tumor accompanied by proliferation of capillaries.
Although SFT frequently occurs on the pleura, a
growing number of SFT cases have been reported
in extrapleural locations.1 However, SFT in the oral
cavity is rare, especially in the tongue, where only
seven cases have been reported so far (Table 2).2–7
The tumors were all observed after the fourth dec-
ade of life, and the mean age was 58.1 years, with
a range from 44 to 80. For unknown reasons, more
cases have been reported in women.
Of great importance for confirmation of SFT
diagnosis is CD34 expression. CD34 is a 110 kDa
single-chain transmembrane glycoprotein of un-
known function, which is present on haematopoi-
etic precursors and capillary endothelial cells.
While almost all SFT cases are positive for CD34,
this glycoprotein is not specific for SFT; other tu-
mors such as neurofibroma, schwannoma, leiomy-
oma are sometimes positive for CD34. Therefore,
the exclusion of other tumors of mesenchymal ori-
gin is essential for a diagnosis of SFT.1 The present
case met the histological criteria for SFT and
matched well with the previously reported SFT
Figure 2 Immunohistochemistry. (A) CD34 is strongly positive. (B) and (C) SMA is positive in the capillaries (B) and
also in some tumor cells that do not constitute capillaries (C). (D) and (E) Most of the tumor cells are positive for VEGF
(D) and VEGF-R (E). (F) The labeling index of p53 is approximately 50%. Note that the capillary cells are sometimes
positive for p53 (arrows) (original magnification: A, B, D–F: ·200, C: ·400).
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positive whereas S-100 was negative. Although at
least half of extraoral SFTs are positive for CD99,1
they appear to be uncommon in the intraoral re-
gion, where a majority of the cases were reported
to be negative for CD99,4 as was our present case.
Capillary proliferation and a pericytic pattern
of tumor cell proliferation are often prominent
in SFTs, which sometimes makes them resemble
hemangiopericytoma. The distinction is made
based on the presence of thick collagen bands be-
tween the tumor cells.1 Expression of capillary
markers such as vWf, SMA and Desmin varies among
cases. This may be due to the variation of differen-
tiation of the tumor cells. In the present case, we
found expression of SMA in some tumor cells which
seemed to be on the way to capillary formation,
indicating an angiogenic differentiation of the
tumor cells. We assume that the microcapillariesin the tumor, at least in part, were derived from
tumor cells because many of the cells of these
microcapillaries were positive for p53 (Fig. 2F),
compared to the low positivity in the normal capil-
lary cells. We also found that the two most impor-
tant angiogenic factors, VEGF and bFGF, were
strongly expressed in the tumor cells, as were their
respective receptors (VEGF-R and FGF-R), indicat-
ing that elevated expression of these factors may
lead the cells to angiogenic differentiation.
A few SFTs demonstrate features that predict
malignant potential, including high cellularity, cel-
lular pleomorphism, a high mitotic index and tumor
cell necrosis.1 The present case showed only a par-
tial-high cellularity, and the labeling index of Ki-67
was low, which suggests that this tumor was a be-
nign neoplasm. However, the high labeling index
of p53 should be cautiously considered as a warning
sign of possible malignant transformation.
Table 1 Summary of the results of immunohistochemical examination. Immunoreactivity was evaluated by the
percentage of the positively stained cells and graded as (); <5%, (+); 5–25%, (++); 25%<. For Ki-67, Bcl-2 and p53,
labeling index (LI) was calculated by counting at least 100 cells in different 10 fields
Antibody (clone; manufacturer) Dilution Pretreatment Immunoreactivity (LI)
EMA (E29; DAKO) 1:100 Trypsine 
Vimentin (V9; DAKO) 1:50 – ++
CD31 (JC/70A; DAKO) 1:100 Autoclave 
CD34 (NU-4A1; Nichirei) 1:100 – ++
CD99 (12E7; DAKO) 1:75 – 
SMA (1A4; DAKO) 1:50 – +
Desmin (D33; DAKO) 1:100 – 
vWf (; DAKO) 1:400 – 
S-100 (; DAKO) 1:800 – 
Ki-67 (; DAKO) 1:100 Autoclave + (<10%)
Bcl-2 (124; DAKO) 1:50 Autoclave ++ (60%)
p53 (DO-7; DAKO) 1:100 Autoclave ++ (50%)
MDM2 (SMP14; DAKO) 1:50 Autoclave 
VEGF (1-26; TaKaRa) 1:200 Microwave ++
VEGF-R2 (A-3; Santa Cruz) 1:200 Microwave ++
bFGF (014-14291; Wako) 1:100 Microwave ++
FGF-R (VBS7; Wako) 1:50 – +
Table 2 Summary of the previously reported SFTs of tongue
Report Age Sex Size (cm) Vimentin CD34 vWf SMA Desmin S-100 Bcl2 p53 Ki67
Piattelli et al. (Ref. 2) 66 M 1 + ++   ++ <10%
Alawi et al. (Ref. 3) 44 F 1.1 ++ ++ + +
Alawi et al. (Ref. 3) 48 F 0.8 ++ ++ + +
Vargas et al. (Ref. 4) 65 F 4.8 ++ ++    ++  <10%
Wu et al. (Ref. 5) 70 F 1.6 ++  +  ++
Yamashita et al. (Ref. 6) 75 F 3 ++ ++    
Shnayder et al.a (Ref. 7) 57 F 2.5 ++ ++    + + 20%
Sakamoto et al. 80 F 2.5 ++ ++  +   + + <10%
a Malignant SFT.
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